The Effect of Viral Suppression on Cross-Sectional Incidence Testing in the Johns Hopkins Hospital Emergency Department
- 1 June 2008
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 48 (2) , 211-215
- https://doi.org/10.1097/qai.0b013e3181743980
Abstract
Objective(s): To determine the effect of viral suppression on cross-sectional incidence testing. Methods: In 2001 and 2003, patients entering the Johns Hopkins Hospital (JHH) Emergency Department (ED) were enrolled into an interview-based identity-unlinked serosurvey. All HIV-positive samples were tested by the Vironostika-less sensitive (LS) enzyme immunoassay (EIA) (Organon-Teknika, Charteston, SC) and an avidity assay to determine recent HIV infection. Additionally 16 samples from 8 previously characterized elite suppressors (ES) were tested by cross-sectional incidence assays. Results: HIV prevalence was 12% for the 2001 survey and 11% for the 2003 survey. Of the HIV-infected subjects, 18% did not know they were infected. The Vironostika-LS EIA determined that 6% (11 of 183) and 7% (17 of 243) of HIV-positive individuals in 2001and 2003, respectively, were recently infected. Avidity testing confirmed that 6 of 11 in 2001 and 5 of 17 in 2003 were newly infected, leaving 17 discrepant samples. All 17 discrepant samples were Western blot-positive and viral load undetectable, and 7 of 17 had antiretroviral drugs (ARVs) in their serum. Ten individuals were virally suppressed without ARVs and seemed incident by the Vironostika-LS EIA but chronic by avidity testing. These 10 subjects had similar testing profiles to the known 16 ES samples, because 9 of 16 were incident by the Vironostika-LS EIA and 0 of 16 were incident by avidity testing. Conclusions: By removing the viral load-negative individuals and confirming the initial Vironostika-LS EIA results by avidity testing, the incidence estimate was lowered from 1.73% to 0.94% per year in 2001 and from 1.90% to 0.56% per year in 2003. Viral suppression affects the performance of the cross-sectional incidence tests, which rely on antibody titer. In addition, 2% (10 of 426) of all HIV-infected individuals who use the JHH ED for medical care seem to suppress HIV to undetectable levels without ARVs.Keywords
This publication has 20 references indexed in Scilit:
- Assessment of Recent HIV-1 Infection by a Line Immunoassay for HIV-1/2 ConfirmationPLoS Medicine, 2007
- Neutralizing Antibodies Do Not Mediate Suppression of Human Immunodeficiency Virus Type 1 in Elite Suppressors or Selection of Plasma Virus Variants in Patients on Highly Active Antiretroviral TherapyJournal of Virology, 2006
- Comparison of the Avidity Index Method and the Serologic Testing Algorithm for Recent Human Immunodeficiency Virus (HIV) Seroconversion, Two Methods Using a Single Serum Sample for Identification of Recent HIV InfectionsJournal of Clinical Microbiology, 2005
- Development and Validation of an Immunoassay for Identification of Recent Human Immunodeficiency Virus Type 1 Infections and Its Use on Dried Serum SpotsJournal of Clinical Microbiology, 2005
- Modification of Rapid Human Immunodeficiency Virus (HIV) Antibody Assay Protocols for Detecting Recent HIV SeroconversionClinical and Vaccine Immunology, 2005
- Detection of Acute Infections during HIV Testing in North CarolinaNew England Journal of Medicine, 2005
- Evaluation of a Sensitive/Less Sensitive Testing Algorithm Using the bioMérieux Vironostika-LS Assay for Detecting Recent HIV-1 Subtype B' or E Infection in ThailandAIDS Research and Human Retroviruses, 2003
- Precision and Accuracy of a Procedure for Detecting Recent Human Immunodeficiency Virus Infections by Calculating the Antibody Avidity Index by an Automated Immunoassay-Based MethodJournal of Clinical Microbiology, 2002
- Quantitative Detection of Increasing HIV Type 1 Antibodies after Seroconversion: A Simple Assay for Detecting Recent HIV Infection and Estimating IncidenceAIDS Research and Human Retroviruses, 2002
- Feasibility of an Emergency Department–Based, Risk-Targeted Voluntary HIV Screening ProgramAnnals of Emergency Medicine, 1996